L.J. Altfest & Co’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $786K | Buy |
1,766
+120
| +7% | +$53.4K | 0.09% | 151 |
|
|
2025
Q1 | $798K | Buy |
1,646
+975
| +145% | +$473K | 0.1% | 144 |
|
|
2024
Q4 | $270K | Sell |
671
-972
| -59% | -$391K | 0.03% | 281 |
|
|
2024
Q3 | $764K | Buy |
1,643
+171
| +12% | +$79.5K | 0.1% | 155 |
|
|
2024
Q2 | $690K | Buy |
1,472
+35
| +2% | +$16.4K | 0.09% | 150 |
|
|
2024
Q1 | $601K | Buy |
1,437
+5
| +0.3% | +$2.09K | 0.09% | 170 |
|
|
2023
Q4 | $583K | Sell |
1,432
-18
| -1% | -$7.33K | 0.08% | 166 |
|
|
2023
Q3 | $504K | Sell |
1,450
-82
| -5% | -$28.5K | 0.08% | 177 |
|
|
2023
Q2 | $539K | Buy |
1,532
+76
| +5% | +$26.7K | 0.08% | 173 |
|
|
2023
Q1 | $459K | Buy |
1,456
+176
| +14% | +$55.5K | 0.07% | 179 |
|
|
2022
Q4 | $370K | Sell |
1,280
-1,175
| -48% | -$340K | 0.06% | 188 |
|
|
2022
Q3 | $711K | Sell |
2,455
-3
| -0.1% | -$869 | 0.13% | 109 |
|
|
2022
Q2 | $693K | Sell |
2,458
-569
| -19% | -$160K | 0.12% | 116 |
|
|
2022
Q1 | $790K | Buy |
3,027
+81
| +3% | +$21.1K | 0.14% | 114 |
|
|
2021
Q4 | $647K | Sell |
2,946
-15
| -0.5% | -$3.29K | 0.12% | 124 |
|
|
2021
Q3 | $537K | Buy |
2,961
+1,170
| +65% | +$212K | 0.11% | 131 |
|
|
2021
Q2 | $361K | Buy |
1,791
+216
| +14% | +$43.5K | 0.08% | 186 |
|
|
2021
Q1 | $338K | Buy |
1,575
+22
| +1% | +$4.72K | 0.08% | 194 |
|
|
2020
Q4 | $367K | Buy |
+1,553
| New | +$367K | 0.09% | 167 |
|